These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11732397)

  • 21. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 22. [The new drug cost saving package. Sensible measures or risk for patients?].
    Krankenpfl J; 2002; 40(5-6):159. PubMed ID: 12271499
    [No Abstract]   [Full Text] [Related]  

  • 23. [General practitioner covers practices of health insurance. How will the physicians be treated concerning compensations?].
    Schmidt K
    MMW Fortschr Med; 2005 Apr; 147(14):40-1. PubMed ID: 15887683
    [No Abstract]   [Full Text] [Related]  

  • 24. [Political measures have a long-term effect on the drug industry].
    Engelhorn C
    Fortschr Med; 1980 Apr; 98(14):501-2, 544. PubMed ID: 7372245
    [No Abstract]   [Full Text] [Related]  

  • 25. Bare-bones health plans: are they worth the money?
    Glied S; Callahan C; Mays J; Edwards JN
    Issue Brief (Commonw Fund); 2002 May; (518):1-4. PubMed ID: 11993501
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 27. New rules for US drug reimbursement.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
    [No Abstract]   [Full Text] [Related]  

  • 28. It's time for the industry to move on from ROI.
    Duncan I
    Dis Manag; 2004; 7(3):159-60. PubMed ID: 15669576
    [No Abstract]   [Full Text] [Related]  

  • 29. [Follow up studies as a condition for drug subsidizing].
    Kieler H; Ekbom A; Fored M; Montgomery SM; Wettermark B
    Lakartidningen; 2009 May 13-19; 106(20):1406-7. PubMed ID: 19585842
    [No Abstract]   [Full Text] [Related]  

  • 30. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National estimates of medical costs incurred by nonelderly cancer patients.
    Howard DH; Molinari NA; Thorpe KE
    Cancer; 2004 Mar; 100(5):883-91. PubMed ID: 14983481
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacies receiving massive rebates from generic drug-makers.
    Silversides A
    CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
    [No Abstract]   [Full Text] [Related]  

  • 33. Why health reform will bend the cost curve.
    Cutler DM; Davis K; Stremikis K
    Issue Brief (Commonw Fund); 2009 Dec; 72():1-16. PubMed ID: 19998565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials: considerations for researchers and hospital administrators.
    Uecke O; Reszka R; Linke J; Steul M; Posselt T
    Health Care Manage Rev; 2008; 33(2):103-12. PubMed ID: 18360161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
    Rai AK
    Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical industry research and cost savings in community-acquired pneumonia.
    Kessler LA; Waterer GW; Barca R; Wunderink RG
    Am J Manag Care; 2002 Sep; 8(9):798-800. PubMed ID: 12234020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Always more specific care centers. Insurance steals private patients from family physicians].
    MMW Fortschr Med; 2004 Nov; 146(45):58-9. PubMed ID: 15581110
    [No Abstract]   [Full Text] [Related]  

  • 39. Self-pay markets in health care: consumer Nirvana or caveat emptor?
    Tu HT; May JH
    Health Aff (Millwood); 2007; 26(2):w217-26. PubMed ID: 17284468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug 'ediction'. This pilot program could mean massive Medicaid dollar savings for LTC facilities.
    Clark T
    Contemp Longterm Care; 2003 Apr; 26(4):34-7. PubMed ID: 12698897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.